151 related articles for article (PubMed ID: 38545373)
41. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA expression profiling in exosomes derived from gastric cancer stem-like cells.
Sun ZP; Li AQ; Jia WH; Ye S; Van Eps G; Yu JM; Yang WJ
Oncotarget; 2017 Nov; 8(55):93839-93855. PubMed ID: 29212193
[TBL] [Abstract][Full Text] [Related]
44. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
45. The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.
Sweef O; Yang C; Wang Z
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289596
[TBL] [Abstract][Full Text] [Related]
46. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
Deng J; Yang M; Jiang R; An N; Wang X; Liu B
PLoS One; 2017; 12(1):e0170860. PubMed ID: 28122024
[TBL] [Abstract][Full Text] [Related]
47. Panoramic view of microRNAs in regulating cancer stem cells.
Zhao Y; Wei D; Zhang Y; Ji J
Essays Biochem; 2022 Sep; 66(4):345-358. PubMed ID: 35996948
[TBL] [Abstract][Full Text] [Related]
48. Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids.
Park H; Hwang S; Jeong JY; Jung SG; Choi MC; Joo WD; Song SH; Lee C; An HJ
J Ovarian Res; 2020 Feb; 13(1):16. PubMed ID: 32046751
[TBL] [Abstract][Full Text] [Related]
49. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
[TBL] [Abstract][Full Text] [Related]
50. HOXA9 Overexpression Contributes to Stem Cell Overpopulation That Drives Development and Growth of Colorectal Cancer.
Osmond B; Facey COB; Zhang C; Boman BM
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743243
[TBL] [Abstract][Full Text] [Related]
51. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
52. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
53. Oncogenic micro-RNAs and Renal Cell Carcinoma.
Grange C; Collino F; Tapparo M; Camussi G
Front Oncol; 2014; 4():49. PubMed ID: 24672771
[TBL] [Abstract][Full Text] [Related]
54. Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.
Zhou F; Tang D; Xu Y; He H; Wu Y; Lin L; Dong J; Tan W; Dai Y
BMC Cancer; 2020 Mar; 20(1):242. PubMed ID: 32293320
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
[TBL] [Abstract][Full Text] [Related]
56. Construction of endogenous RNA regulatory network for colorectal cancer based on bioinformatics.
Li Y; Yuan F; Lin Z; Pan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):416-430. PubMed ID: 35545337
[TBL] [Abstract][Full Text] [Related]
57. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
58. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
59. Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
Ueda K; Ogasawara S; Akiba J; Nakayama M; Todoroki K; Ueda K; Sanada S; Suekane S; Noguchi M; Matsuoka K; Yano H
PLoS One; 2013; 8(10):e75463. PubMed ID: 24116047
[TBL] [Abstract][Full Text] [Related]
60. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]